Related Experiment Video
Updated: Aug 14, 2025

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
ABRO1 arrests cardiomyocyte proliferation and myocardial repair by suppressing PSPH
Tao Wang1, Lu-Yu Zhou2, Xin-Min Li2
1Institute for Translational Medicine, The Affiliated Hospital of Qingdao University, College of Medicine, Qingdao University, Qingdao 266021, China; Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan 250014, China.
Abstract:
The role of Abraxas 2 (ABRO1 or KIAA0157), a component of the lysine63-linked deubiquitinating system, in the cardiomyocyte proliferation and myocardial regeneration is unknown. Here, we found that ABRO1 regulates cardiomyocyte proliferation and cardiac regeneration in the postnatal heart by targeting METTL3-mediated m6A methylation of Psph mRNA. The deletion of ABRO1 increased cardiomyocyte proliferation in hearts and restored the heart function after myocardial injury. On the contrary, ABRO1 overexpression significantly inhibited the neonatal cardiomyocyte proliferation and cardiac regeneration in mouse hearts. The mechanism by which ABRO1 regulates cardiomyocyte proliferation mainly involved METTL3-mediated Psph mRNA methylation and CDK2 phosphorylation. In the early postnatal period, METTL3-dependent m6A methylation promotes cardiomyocyte proliferation by hypermethylation of Psph mRNA and upregulating PSPH expression. PSPH dephosphorylates cyclin-dependent kinase 2 (CDK2), a positive regulator of cell cycle, at Thr14/Tyr15 and increases its activity. Upregulation of ABRO1 restricts METTL3 activity and halts the cardiomyocyte proliferation in the postnatal hearts. Thus, our study reveals that ABRO1 is an essential contributor in the cell cycle withdrawal and attenuation of proliferative response in the postnatal cardiomyocytes and could act as a potential target to accelerate cardiomyocyte proliferation and cardiac repair in the adult heart.
Insights
Abraxas 2 (ABRO1) regulates cardiomyocyte proliferation and cardiac repair by influencing METTL3-mediated m6A methylation. Its deletion promotes heart regeneration, while its overexpression inhibits it.
Area of Science:
- Cardiovascular Biology
- Molecular and Cellular Cardiology
- Epigenetics
Background:
- The role of Abraxas 2 (ABRO1) in cardiomyocyte proliferation and myocardial regeneration remains unclear.
- ABRO1 is a component of the lysine63-linked deubiquitinating system.
Purpose of the Study:
- To investigate the function of ABRO1 in cardiomyocyte proliferation and cardiac regeneration.
- To elucidate the molecular mechanism by which ABRO1 regulates these processes.
Main Methods:
- Investigated ABRO1's role in mouse models with ABRO1 deletion or overexpression.
- Analyzed cardiomyocyte proliferation, cardiac function after myocardial injury, and molecular pathways involving METTL3, m6A methylation, Psph mRNA, and CDK2 phosphorylation.
Main Results:
- ABRO1 deletion enhanced cardiomyocyte proliferation and restored heart function post-injury.
- ABRO1 overexpression inhibited neonatal cardiomyocyte proliferation and cardiac regeneration.
- ABRO1 regulates cardiomyocyte proliferation via METTL3-mediated Psph mRNA methylation and subsequent CDK2 phosphorylation, controlling cell cycle progression.
Conclusions:
- ABRO1 is crucial for cell cycle withdrawal and reduced proliferation in postnatal cardiomyocytes.
- ABRO1 acts as a negative regulator of cardiac regeneration.
- ABRO1 represents a potential therapeutic target for enhancing cardiomyocyte proliferation and cardiac repair in adult hearts.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Rheumatic Heart Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction
Pathophysiology of Heart Failure

